Stijn de Jong

Stijn specialises in European competition and consumer law and has extensive experience handling high‑profile and cutting‑edge government investigations and litigations.

Image
Stijn de Jong Stibbe

Stijn de Jong

Partner Amsterdam

Stijn specialises in European competition and consumer law and has extensive experience handling high‑profile and cutting‑edge government investigations and litigations.

Stijn de Jong

Partner Amsterdam

His practice focuses on competition and consumer litigation matters, government investigations, regulatory approvals, and general counseling. He advises a wide range of clients in diverse industries, including technology, pharmaceuticals, consumer products, life sciences, transport, media and manufacturing. Stijn has contributed articles to leading Dutch and European journals.

In 2024, Stijn was listed in Global Competition Review's 40 Under 40 list, which features the “next generation of leading antitrust practitioners”. 

In 2021, Stijn was seconded to Cravath, Swaine & Moore LLP in New York.

Languages: Dutch, English
Admitted to the Amsterdam Bar: 2016
Partner since: 2024
Office building
Matter
NL Law

Stibbe behaalt overwinning voor Sena in toezichtszaak over transparantieverplichtingen

In 2018 heeft het College van Toezicht Auteursrechten (CvTA) Sena een bindende instructie gegeven om bepaalde overeenkomsten met NPO, RPO en NLPO als standaardlicentieovereenkomsten en tarieven op haar website te publiceren.

Continue reading
Office building
Matter
NL Law

Stibbe successfully represented Sena in supervisory proceedings concerning transparency obligations

In 2018, the Copyright Supervisory Board (College van Toezicht Auteursrechten, “CvTA”) issued a binding instruction to Sena to publish certain agreements with NPO, RPO, and NLPO as standard license agreements and rates on its website.

Continue reading
Close-up of surgical lights in a hospital operating room
Matter
NL Law

Stibbe advises Viatris in sale of substantially all of Viatris’ European OTC Business to Cooper Consumer Health

Stibbe successfully guides Viatris through EU regulatory processes.

Continue reading
Cropped close-up of a pharmacy's green cross sign
Matter
NL Law
EU Law

Stibbe advises Medios AG

Stibbe advises Medios on its acquisition of Ceban for around EUR 260 mio. Medios is a German pharmaceutical company listed on the Frankfurt stock exchange. Dutch Ceban prepares medicines for hospitals and pharmacies, also known as compounding.

Continue reading